Table 1.
Characteristics of the patients.
| HIV– HCV– | HIV– HCV+ | HIV+ HCV– | HIV+ HCV+ | |
|---|---|---|---|---|
| Number of patients | 19 | 11 | 42 | 27 |
| Age* | 38 ± 10 | 52 ± 12 | 42 ± 12 | 41 ± 8 |
| Male/female | 12/7 | 6/5 | 25/17 | 16/11 |
| Years of HIV infection | 5 ± 4 | 13 ± 5 | ||
| Antiretroviral therapy with PI | 13 | 11 | ||
| Antiretroviral therapy PI sparing | 19 | 13 | ||
| No therapy | 10 | 3 | ||
| CD4+ cell count/mm3 | 910 ± 344 | 889 ± 348 | 379 ± 252 | 470 ± 322 |
| HIV-RNA (copies/ml) | 24 979 ± 88 047 | 28 621 ± 97 886 | ||
| ALT** | 22 ± 12 | 81 ± 51 | 28 ± 23 | 66 ± 58 |
| AST*** | 21 ± 10 | 73 ± 62 | 26 ± 17 | 53 ± 39 |
| HCV RNA (copies/ml) | 949 046 ± 1 448 910 | 1 116 710 ± 1 680 410 | ||
| HCV genotype 1 | 5 | 15 | ||
| HCV genotypes 2, 3 and 4 | 6 | 12 |
Data are expressed as mean values ± standard deviation.
*
P = 0·009
**
P = 0·001
***
P = 0·001.
AST: aspartate aminotransferase; ALT: alanine aminotransferase.